Hematology and Oncology Fellowship

Olympia Fields is a nationally recognized leader in healthcare and serves as the primary clinical training site for the Hematology and Medical Oncology Fellowship Program.

With a strong commitment to excellence in patient care, education, and research, the hospital is at the forefront of cancer care, offering cutting-edge services in hematologic malignancies, solid tumors, and supportive oncology.

The Comprehensive Cancer Institute at Olympia Fields is an American College of Surgeons (ACS)-approved Teaching Hospital Cancer Program, reflecting its dedication to delivering the highest standards of oncologic care. It holds prestigious accreditations from the American College of Surgeons in the National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC), underscoring its leadership in multidisciplinary cancer treatment and quality improvement.

Fellows will complete the majority of their clinical rotations and educational experiences, ensuring a cohesive and immersive training environment. This setting provides broad exposure to a diverse patient population and a wide spectrum of hematologic and oncologic conditions, preparing fellows for independent practice and board certification.

In addition to comprehensive cancer services, the hospital offers robust support in areas integral to hematology/oncology care, including palliative and hospice care, pain management, behavioral health, rehabilitation, advanced imaging, and surgical oncology.

Fellows will work closely with a multidisciplinary team of board-certified faculty and specialists who are deeply committed to mentorship, clinical excellence, and the professional development of each trainee.

Deliver Comprehensive, Patient-Centered Clinical Training

Hematology and Medical Oncology program aims to provide its fellows with immersive, hands-on experience in diagnosing and managing a wide range of hematologic and oncologic conditions across inpatient, outpatient, and consultative settings. The program will emphasize compassionate, evidence-based care that respects the values and needs of diverse patient populations.

Foster Lifelong Learning and Scholarly Excellence

We endeavor to cultivate a culture of intellectual curiosity and continuous learning through structured didactics, journal clubs, and active participation in clinical research, quality improvement projects, and clinical trials when possible. The fellows will be encouraged to contribute to the advancement of the hematology and medical oncology field through scholarly dissemination.

Develop Future Leaders in Hematology and Oncology

The program will provide progressive autonomy and leadership opportunities throughout the fellowship, including roles in teaching, multidisciplinary collaboration, and institutional initiatives. The fellows will be supported in developing the skills necessary to lead in academic, community, and policymaking environments.

Ensure Personalized Mentorship and Professional Development

Each fellow will be paired with dedicated faculty mentors who will help guide their clinical, academic, and career growth. Individualized support will be offered for board preparation, career planning, and the pursuit of subspecialty interests or academic pathways.

Align with Institutional Mission to Serve the Community

The program aims to integrate fellows into institutional and community-based initiatives that promote public health, cancer prevention, and outreach. This will reinforce the program’s commitment to improving the health of the communities served by Olympia Fields.

• Affiliated Oncologists- Chicago Ridge

• Olympia Fields – Hospital

• Affiliated Oncologists- Orland Park

Didactic Sessions

Faculty from both hematology and medical oncology deliver lectures on core disease topics and areas of active research. These sessions aim to build foundational knowledge and expose fellows to current advancements to ensure broad and balanced coverage

New Patient Conference (NPC)

Held monthly, this conference focuses on the presentation of a solid tumor oncology case. Fellows present the case, followed by a discussion on standard evaluation and treatment approaches, guided by a faculty attending. As the program matures, there are expansion plans to include thoracic oncology, gynecologic oncology, and radiation oncology faculty to enrich the multidisciplinary perspective.

Hematopathology Conference

This is a weekly fellow-led conference where one fellow presents interesting cases in both malignant and benign hematology. Each session includes a discussion of relevant hematology board review questions.

Tumor Boards

Fellows will attend and present at various tumor boards, including breast, general, and urology tumor boards, which occur biweekly. These meetings provide valuable exposure to multidisciplinary case discussions and collaborative decision-making.

Journal Club

Conducted monthly, one fellow presents a critical review of two recent high-impact publications, with insights from faculty. As the fellowship cohort grows, we anticipate increasing the frequency of these sessions.

Hematology/Oncology Grand Rounds

Each fellow is expected to deliver a 30-minute Grand Rounds presentation during their second or third year. This provides an opportunity to develop presentation skills and share scholarly work with the broader department.

Board Review

In preparation for the ASCO and ASH in-service exams and third-year board certification, fellows participate in structured and informal board review sessions. These include practice questions and review of board-focused materials.

Morbidity & Mortality (M&M) / Adverse Event Analysis: Fellows lead quarterly M&M conferences, analyzing adverse events in hematology and oncology patients. These sessions foster a culture of safety, reflection, and continuous improvement